X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2024) 2024
Publication (138) 138
Newsletter (44) 44
Book Review (39) 39
Newspaper Article (15) 15
Book Chapter (7) 7
Magazine Article (5) 5
Conference Proceeding (3) 3
Dissertation (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1463) 1463
formoterol (1213) 1213
index medicus (961) 961
asthma (946) 946
formoterol fumarate (835) 835
male (816) 816
respiratory system (793) 793
asthma - drug therapy (780) 780
female (777) 777
administration, inhalation (750) 750
middle aged (652) 652
adult (606) 606
salmeterol (602) 602
bronchodilator agents - administration & dosage (597) 597
budesonide (596) 596
ethanolamines - administration & dosage (548) 548
drug therapy, combination (541) 541
pulmonary disease, chronic obstructive - drug therapy (514) 514
treatment outcome (508) 508
drug combinations (480) 480
aged (470) 470
bronchodilator agents - therapeutic use (447) 447
ethanolamines - therapeutic use (399) 399
copd (375) 375
drug therapy (371) 371
budesonide - administration & dosage (366) 366
pharmacology & pharmacy (366) 366
double-blind method (361) 361
obstructive pulmonary-disease (316) 316
exacerbations (307) 307
adolescent (306) 306
albuterol - analogs & derivatives (304) 304
lung diseases, obstructive (303) 303
efficacy (302) 302
chronic obstructive pulmonary disease (301) 301
fluticasone (289) 289
corticosteroids (286) 286
budesonide - therapeutic use (257) 257
budesonide/formoterol (257) 257
salmeterol xinafoate (254) 254
safety (251) 251
tiotropium (241) 241
inhaled corticosteroids (238) 238
bronchodilator agents - adverse effects (237) 237
adrenal cortex hormones - administration & dosage (234) 234
anti-asthmatic agents - administration & dosage (233) 233
pulmonary disease, chronic obstructive - physiopathology (232) 232
fluticasone propionate (224) 224
asthma - physiopathology (218) 218
medicine, general & internal (217) 217
albuterol - administration & dosage (216) 216
dosage and administration (207) 207
ethanolamines - adverse effects (205) 205
albuterol - therapeutic use (204) 204
anti-asthmatic agents - therapeutic use (204) 204
child (204) 204
allergy (203) 203
therapy (201) 201
combination (200) 200
double-blind (197) 197
adrenergic beta-agonists - administration & dosage (194) 194
care and treatment (193) 193
adrenergic beta-2 receptor agonists - administration & dosage (191) 191
pulmonary/respiratory (189) 189
research (189) 189
pulmonary and respiratory medicine (186) 186
forced expiratory volume (180) 180
quality of life (180) 180
adrenergic beta-agonists - therapeutic use (178) 178
single inhaler (178) 178
nebulizers and vaporizers (176) 176
randomized controlled trials as topic (174) 174
adrenal cortex hormones - therapeutic use (170) 170
dose-response relationship, drug (170) 170
respiratory tract diseases (168) 168
cardiac & cardiovascular systems (164) 164
time factors (164) 164
forced expiratory volume - drug effects (163) 163
combination therapy (161) 161
immunology (160) 160
analysis (159) 159
clinical trials (154) 154
metered dose inhalers (154) 154
salbutamol (154) 154
androstadienes - administration & dosage (153) 153
cross-over studies (151) 151
drug administration schedule (151) 151
young adult (150) 150
severity of illness index (149) 149
steroids (148) 148
respiratory function tests (136) 136
aged, 80 and over (135) 135
glucocorticoids - administration & dosage (135) 135
antiasthmatic agents (134) 134
management (131) 131
moderate (129) 129
ethanolamines - pharmacology (127) 127
metered-dose inhaler (127) 127
diseases of the respiratory system (125) 125
formoterol fumarate - administration & dosage (125) 125
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1981) 1981
German (46) 46
Spanish (21) 21
French (14) 14
Russian (10) 10
Japanese (8) 8
Polish (5) 5
Portuguese (4) 4
Chinese (2) 2
Turkish (2) 2
Danish (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Internal Medicine, ISSN 0003-4819, 04/2007, Volume 146, Issue 8, pp. 545 - 555
Journal Article
Respiratory Research, ISSN 1465-9921, 01/2017, Volume 18, Issue 1, p. 8
Journal Article
Journal Article
International Journal of COPD, ISSN 1176-9106, 06/2015, Volume 10, pp. 1015 - 1026
Background: The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one or more bronchodilators... 
Clinical trial | agonists | Long-acting muscarinic antagonist | Long-acting β | COPD | clinical trial | COST-EFFECTIVENESS | SAFETY | INHALED CORTICOSTEROIDS | SALMETEROL | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | PRIMARY-CARE | FLUTICASONE PROPIONATE | RESPIRATORY SYSTEM | DOUBLE-BLIND | TIOTROPIUM | long-acting beta-agonists | long-acting muscarinic antagonist | Bronchodilator Agents - therapeutic use | Indans - adverse effects | Spirometry | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Fluticasone-Salmeterol Drug Combination - therapeutic use | Pulmonary Disease, Chronic Obstructive - physiopathology | Muscarinic Antagonists - therapeutic use | Indans - therapeutic use | Recovery of Function | Fluticasone-Salmeterol Drug Combination - adverse effects | Forced Expiratory Volume | Quinolones - adverse effects | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Quinolones - therapeutic use | Adrenergic beta-2 Receptor Agonists - therapeutic use | Adult | Female | Surveys and Questionnaires | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Glucocorticoids - adverse effects | Glycopyrrolate - adverse effects | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Double-Blind Method | Glycopyrrolate - therapeutic use | Administration, Inhalation | Treatment Outcome | Lung - physiopathology | Glycopyrrolate - analogs & derivatives | Fluticasone-Salmeterol Drug Combination - administration & dosage | Muscarinic Antagonists - administration & dosage | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Nebulizers and Vaporizers | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Drug therapy, Combination | Comparative analysis | Drug therapy | Methods | Bronchodilator agents
Journal Article
Journal Article
Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 06/2013, Volume 273, Issue 6, pp. 584 - 594
Objectives Combinations of inhaled corticosteroids (ICSs) and long‐acting β2‐agonists (LABAs) are recommended for patients with moderate and severe chronic... 
long‐acting β2‐agonists | fluticasone/salmeterol | exacerbations | budesonide/formoterol | inhaled corticosteroids | Exacerbations | Fluticasone/salmeterol | Inhaled corticosteroids | agonists | Budesonide/formoterol | Long-acting β | fluticasone | MANAGEMENT | HEALTHY-SUBJECTS | formoterol | RANDOMIZED CONTROLLED-TRIAL | SALMETEROL/FLUTICASONE | budesonide | PROPIONATE | MEDICINE, GENERAL & INTERNAL | long-acting 2-agonists | salmeterol | BACTERIAL-COLONIZATION | WITHDRAWAL | COPD | Formoterol Fumarate | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Secondary Prevention | Ethanolamines - administration & dosage | Dose-Response Relationship, Drug | Time Factors | Albuterol - administration & dosage | Female | Registries | Retrospective Studies | Drug Therapy, Combination | Administration, Inhalation | Albuterol - analogs & derivatives | Treatment Outcome | Androstadienes - administration & dosage | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Budesonide - administration & dosage | Fluticasone-Salmeterol Drug Combination | Respiratory Function Tests | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Prevention | Medicine, Experimental | Medical research | Lung diseases, Obstructive | Corticosteroids | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Chest, ISSN 0012-3692, 2001, Volume 119, Issue 5, pp. 1347 - 1356
Journal Article
The Cochrane database of systematic reviews, ISSN 1465-1858, 2014, Volume 6, Issue 8, p. CD010327
Journal Article
14.